The U.S. FDA recently approved the Itovebi-based regimen as a first-line treatment for people with HR+, Her2-negative breast ...
The quality of digital PCR data can only be as high as the assays used to obtain it. High-quality assays ensure that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback